Hemp grower Eviana lands CA$10 million investment from Organigram

Organigram Holdings continues to bet big on CBD with a multimillion-dollar investment in European hemp grower Eviana Health.

The deal charts a path for Organigram to continue its efforts to expand into international markets and ramp up its sales of CBD oil – a strategy the firm’s CFO, Paola De Luca, laid out for Marijuana Business Daily in April. 

Under the agreement, Organigram is making a 10 million Canadian dollar cash investment ($7.7 million), giving the company a 26% equity stake in Eviana, which has operations in Europe and Canada, the companies announced Monday.

Terms of the deal also allow Organigram to buy up to 50% of Eviana’s annual CBD oil at 95% of the wholesale price for up to five years.

“Our investment and concurrent offtake agreement with Eviana will provide Organigram with a source of low-cost, high-quality CBD for the burgeoning medical market within Europe,” Greg Engel, CEO of Organigram said in a news release.

Organigram’s cannabis oil sales tripled in the latest quarter – helping boost profits and sales for the Moncton, New Brunswick-based licensed cultivator.

The firm posted net income of CA$1.1 million in the fiscal quarter ended Feb. 28, 2018, up from red ink of CA$5.7 million in the previous year.

The firm sold 552 liters of cannabis oil in the quarter, compared with 139 liters in the same quarter of 2017.

Subscribe to our Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *